Background. Recent clinical trials in the Lao People's Democratic Republic have
demonstrated that chloroquine and sulfadoxine-pyrimethamine, which are national malaria …

Malaria is a clear example of a reemerging disease. The annual number of cases
(incidence) fell sharply 30-35 years ago as the result of a malaria eradication campaign (1 …

Abstract Background The World Health Organization (WHO) recommends Artemisinin‐
based Combination Therapy (ACT) for treating uncomplicated Plasmodium falciparum …

Several important developments have occurred in recent years in the chemotherapy for and
prophylaxis of parasitic infections. Although mefloquine is clearly the most effective agent for …

Background. During the period of 1996–1999, we prospectively monitored 243 Javanese
adults and children after arriving in Papua, Indonesia, and microscopically documented …

The deployment of artesunate for severe malaria and the artemisinin combination therapies
(ACTs) for uncomplicated malaria has been a major advance in antimalarial therapeutics …

The increasing frequency of therapeutic failures in falciparum malaria underscores the need
for novel, rapidly effective antimalarial drugs or drug combinations. Atovaquone and …

Malaria causes substantial morbidity and mortality in many of the most resource-limited
areas of the world. In addition, malaria is a threat to travelers to endemic areas and should …

Background Plasmodium vivax accounts for about 40% of all malaria infection in Ethiopia.
Chloroquine (CQ) is the first line treatment for confirmed P. vivax malaria in the country. The …